Abstract
This work, based on pharmacophore modeling, aimed to elucidate the three-dimensional structural features of resveratrol derivatives by generating the three-dimensional common pharmacophore responsible for the binding to the inflammation-inducible target. A five points pharmacophore, with three hydrogen bond acceptors and two aromatic rings as pharmacophoric features, was developed. The fit values of the generated pharmacophore are high, except for the Resv34 compound, which could be due to its lowest activity toward cyclooxygenase-2. This pharmacophore yielded a statistically significant atom-based three-dimensional-quantitative structure–activity relationships model with values of R 2, F and standard deviation of 0.9735, 165.4, and 0.2058, respectively, for a training set of twenty-three molecules. Obtained data for a test set of nine compounds with 0.9343, 0.3676, and 0.9694 values for correlation coefficient Q 2, root-mean-square error and Pearson R, respectively, suggested an excellent predictive power of the model. Further, the visualization of the three-dimensional-quantitative structure–activity relationships model provided information about the structure–activity relationships by revealing the importance of electron withdrawing and hydrophobic features, on the chemical structure of compounds for the inhibition of cyclooxygenase-2 enzyme activity. The model therefore provides explicit advances for the design of better resveratrol analogs as cyclooxygenase-2 inhibitors. Thus, the obtained three-dimensional-quantitative structure–activity relationships model can predict novel compounds derived from the low active resveratrol analogs, with improved structures, allowing them to have a better inhibitory effect toward cyclooxygenase-2.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.